Mumbai, India: March 25, 2015 – Sun Pharmaceutical Industries Ltd., begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth. Read the full story

Aspen Pharma, a global branded and generics pharmaceutical manufacturer, has found a place in the top 50 big pharma companies listed by Current Partnering. Read the full story

Aspen Pharmacare specialises in the production of branded and generic pharmaceuticals and is currently the biggest pharmaceutical company in South Africa taking a 15% share of the total market. Read the full story

Sun Pharmaceutical is a global specialty pharmaceutical company serving over 40 different markets with its brands and branded generics. Read the full story

The speciality pharmaceutical company established in 1983 in India has come a long way in the international pharmaceutical industries. The timeline of the company’s business activities since its establishment shows some key partnerships and acquisitions that the company has embarked upon. Read the full story

Sun Pharmaceutical has announced 6 M&A deals since 2009. Read the full story

Ranbaxy is a research based pharmaceutical company with a strong focus on developing generics. Read the full story

STADA is a major global pharmaceutical company offering generics and OTC products. Read the full story

Stada, one of the leading generic pharmaceuticals internationally, enters into acquisitions to increase its market presence in the branded and generics business. Read the full story

Stada, an international generic pharmaceutical company, focuses on products with off-patent active pharmaceutical ingredients. Read the full story